Permeability enhancement techniques for poorly permeable drugs: A review

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 7, 2012, Pages 34-39

  Shaikh, M S I ^a   Derle, Nikita D ^a   Bhamber, Rajendra ^a  

^a MVP Medical Hospital   (India)

Author keywords

BCS; Bioavailability; Epithelium; Parenteral drug delivery; Permeation

Indexed keywords

EID: 84876055612     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2012.2705     Document Type: Article

References (14)

1. Burcin Y., Erem B., Imran V., Murat S. Alternative oral exemestane formulation: Improved dissolution and permeation. Int J Pharmaceutics, 2010; 398:137-145
2. Carsten B., Adrian F., Urte K., Torsten W. Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model. Eur J Pharmaceutics and Biopharmaceutics. 2006; 64: 229-237
3. Dimple P., Fatemeh A., Hossein Z. Intestinal permeability enhancement of levothyroxine sodium by straight chain fatty acids studied in MDCK epithelial cell line. Eur J Pharm Sci. 2010, 40:466-472
4. Edward L. L., Steven C. S. In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement. Advanced Drug Delivery Reviews. 1997; 23: 163-183
5. Ewoud J.V.H., Albertus G. D. B, Douwe D. B.Intestinal drug absorption enhancement: An overview. Pharmac. Ther. 1989; 44: 407-443
6. Fuyuki M., Koji T., Masateru M., Ken-ichi O., Masaaki O., Kazutaka H. , Toshikiro K. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers. International Journal of Pharmaceutics. 2009; 367: 103-108
7. Henry H.Y. T., Zhen D., Geng N. W., H.M. Chan H.M. , Qi C.,Leon C.M. L., Albert H.L. C., Zheng Y.Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. International Journal of Pharmaceutics. 2011; 404: 148-158
8. Mallikarjun C., Kok K. P., Yusrida D., Muthanna A., Ghassan Z. A. , Mohammed J. Q. Intestinal Permeability Studies of Sulpiride Incorporated Into Self-Micro emulsifying Drug Delivery System (SMEDDS). Pak. J. Pharm. Sci. 2011; 24:113-121
9. Masateru M., Takanori M., Hajime T., Masaaki O., Ken-ichi O.,Kazutaka H., Toshikiro K. Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. Journal of Controlled Release. 2006; 115: 130-133
10. Pradeep S., Manthena V.S.V., Harmander P.S. C., Ramesh P. Absorption enhancement, mechanistic and. toxicity studiesof medium chain fatty acids, cyclodextrins and bile saltsas peroral absorption enhancers. Farmaco. 2005; 60: 884-893
11. Seulki L., Sang k. k., Dong Y. L., Kyeongsoon P., Tadiparthi S.,SuY. C., Youngro B. Cationic Analog of Deoxycholate as an Oral Delivery Carrier for Ceftriaxone. Journal of Pharmaceutical Sciences. 2005; 94: 2541-2548
12. Thanou M., Verhoef J.C., Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Advanced Drug Delivery Reviews. 2001; 52: 117-126
13. Van der Merwe S.M., Verhoef J.C., Verheijden J.H.M., Kotze A.F., Junginger H.E. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. European Journal of Pharmaceutics and Biopharmaceutics. 2004; 58: 225-235
14. Xiaole Q., Lishuang W., Jiabi Z., Zhenyi H., Jie Z.Self-doubleemulsifying drug delivery system (SDEDDS): A new way for oral delivery of drugs with high solubility and low permeability. International Journal of Pharmaceutics.2011; 409:245-251